SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-034293
Filing Date
2022-06-03
Accepted
2022-06-03 18:00:18
Documents
2
Period of Report
2022-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1638
2 EX-99 DOCUMENT attachment1.htm EX-99 4600
  Complete submission text file 0001209191-22-034293.txt   7707
Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Issuer) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address
PETERSON TYCHO (Reporting) CIK: 0001927856 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38957 | Film No.: 22996064